Veiga-Parga T
University of Tennessee, Knoxville, TN, USA
Vet Pathol. 2016 Jul;53(4):737-45. doi: 10.1177/0300985816629719. Epub 2016 Mar 4.
In humans and mouse models, Foxp3(+) regulatory T cells are known to control all aspects of immune responses. However, only limited information exists on these cells' role in diseases of other animals. In this review, we cover the most important features and different types of regulatory T cells, which include those that are thymus-derived and peripherally induced, the mechanisms by which they control immune responses by targeting effector T cells and antigen-presenting cells, and most important, their role in animal health and diseases including cancer, infections, and other conditions such as hypersensitivities and autoimmunity. Although the literature regarding regulatory T cells in domestic animal species is still limited, multiple articles have recently emerged and are discussed. Moreover, we also discuss the evidence suggesting that regulatory T cells might limit the magnitude of effector responses, which can have either a positive or negative result, depending on the context of animal and human disease. In addition, the issue of plasticity is discussed because plasticity in regulatory T cells can result in the loss of their protective function in some microenvironments during disease. Lastly, the manipulation of regulatory T cells is discussed in assessing the possibility of their use as a treatment in the future.
在人类和小鼠模型中,已知Foxp3(+)调节性T细胞可控制免疫反应的各个方面。然而,关于这些细胞在其他动物疾病中的作用,目前仅有有限的信息。在这篇综述中,我们涵盖了调节性T细胞的最重要特征和不同类型,包括胸腺来源的和外周诱导的调节性T细胞,它们通过靶向效应T细胞和抗原呈递细胞来控制免疫反应的机制,以及最重要的,它们在动物健康和疾病中的作用,包括癌症、感染以及其他如超敏反应和自身免疫等病症。尽管关于家畜物种中调节性T细胞的文献仍然有限,但最近已有多篇文章出现并在此进行讨论。此外,我们还讨论了表明调节性T细胞可能会限制效应反应强度的证据,这可能会产生积极或消极的结果,具体取决于动物和人类疾病的背景。此外,还讨论了可塑性问题,因为调节性T细胞的可塑性可能会导致它们在疾病期间的某些微环境中失去保护功能。最后,讨论了调节性T细胞的操控,以评估其未来作为一种治疗手段的应用可能性。